Clopidogrel

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Clopidogrel.php on line 2
Clopidogrel

LE WE PMID CA

Clopidogrel

560

Clopidogrel

ABCB1 P glycoprotein

Acetylsalicylic acid Aspirin

Cangrelor

Clopidogrel

CYP2C19

Heart (Atrial fibrillation)

Heart (Coronary heart disease BASKET)

P2Y12

Platelets (BASKET)

Prasugrel

Thrombotic thrombocytopenic purpura

Ticagrelor

Ticlopidine

2009 1	An appraisal of dual antiplatelet therapy with clopidogrel and aspirin for prevention of cardiovascular events. [19124633] J Am Board Fam Med 22(1): 51-6 (2009)
2010 2	Proton pump inhibitors and clopidogrel. [20345494] Cardiovasc Ther 28(3): 169-76 (2010)
2010 3	Modern role for clopidogrel in management of atrial fibrillation and stroke reduction. [20234784] Vasc Health Risk Manag 6(-): 95-103 (2010)
2009 4	Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data? [19373416] Can J Gastroenterol 23(4): 251-2 (2009)
2009 5	The present state of aspirin and clopidogrel resistance. [19644597] Hamostaseologie 29(3): 285-90 (2009)
2008 6	[Methods to evaluate aspirin and clopidogrel resistance]. [18278165] Hamostaseologie 28(1-2): 66-71 (2008)
2006 7	[Resistance to acetylsalicylic acid and clopidogrel: current status]. [16906241] Hamostaseologie 26(3): 229-38 (2006)
1998 8	The antiplatelet effects of ticlopidine and clopidogrel. [9735068] Ann Intern Med 129(5): 394-405 (1998)
2006 9	Clopidogrel pharmacogenetics: promising steps towards patient care? [16857956] Arterioscler Thromb Vasc Biol 26(8): 1681-3 (2006)
2004 10	Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance. [15388526] Arterioscler Thromb Vasc Biol 24(11): 1980-7 (2004)
2008 11	Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). [18574266] Chest 133(6 Suppl): 199S-233S (2008)
2004 12	Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. [15383474] Chest 126(3 Suppl): 234S-264S (2004)
1998 13	Platelet-active drugs: the relationships among dose, effectiveness, and side effects. [9822058] Chest 114(5 Suppl): 470S-488S (1998)
2005 14	Loading, pretreatment, and interindividual variability issues with clopidogrel dosing. [15911717] Circulation 111(20): 2557-9 (2005)
2008 15	Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients. [18826988] Eur Heart J 29(23): 2877-85 (2008)
2006 16	Aspirin and clopidogrel resistance: an emerging clinical entity. [16364973] Eur Heart J 27(6): 647-54 (2006)
2001 17	The platelet ADP receptors. [11325637] Haematologica 86(4): 346-8 (2001)
2009 18	Risk and benefit of proton pump inhibitor for patients undergoing anti-platelet therapy including clopidogrel. [19881232] Intern Med 48(21): 1847-8 (2009)
2009 19	Japan aims toward appropriate concomitant use of antiplatelets and antisecretory agents? [19881231] Intern Med 48(21): 1845-6 (2009)
2004 20	Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. [15494585] JAMA 292(15): 1867-74 (2004)
2009 21	Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care. [19181649] Mayo Clin Proc 84(2): 149-60 (2009)
2008 22	Aspirin and clopidogrel response variability: review of the published literature. [18941611] Tex Heart Inst J 35(3): 313-20 (2008)
2008 23	Clopidogrel and calcium-channel antagonists: another drug-drug interaction for the ever-wary clinician? [19007593] J Am Coll Cardiol 52(19): 1564-6 (2008)
2008 24	Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel. [18206733] J Am Coll Cardiol 51(3): 261-3 (2008)
2007 25	Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. [17418288] J Am Coll Cardiol 49(14): 1505-16 (2007)
2005 26	Resistance to clopidogrel: a review of the evidence. [15837243] J Am Coll Cardiol 45(8): 1157-64 (2005)
2011 27	Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis. [21816733] BMJ 343(-): d4588 (2011)
2004 28	Clopidogrel resistance: a new chapter in a fast-moving story. [15226220] Circulation 109(25): 3064-7 (2004)
2010 29	Genotyping, clopidogrel metabolism, and the search for the therapeutic window of thienopyridines. [20083686] Circulation 121(4): 481-3 (2010)
2009 30	Proton pump inhibitors and clopidogrel: putting the interaction in perspective. [19933929] Circulation 120(23): 2310-2 (2009)
2009 31	P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. [19633016] Eur Heart J 30(16): 1964-77 (2009)
2004 32	Editorial comment--an approach to the estimation of the risk of TTP during clopidogrel therapy. [14757895] Stroke 35(2): 537-8 (2004)
2009 33	Optimizing antiplatelet therapy in high-risk patients with atrial fibrillation: insights from Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE A). [19875732] Stroke 40(12): 3883-5 (2009)
2007 34	Aspirin and clopidogrel resistance. [18024618] Hematology Am Soc Hematol Educ Program -(-): 114-20 (2007)
2011 35	Clopidogrel resistance: current aspects and future directions. [21642072] Hellenic J Cardiol 52(3): 236-45 (2011)
2010 36	Clopidogrel and cardiovascular diseases: recommendations for its correct use. [20118052] Hellenic J Cardiol 51(1): 83-6 (2010)
2007 37	Resistance to aspirin and clopidogrel: possible mechanisms, laboratory investigation, and clinical significance. [18196658] Hellenic J Cardiol 48(6): 352-63 (2007)
2010 38	Aspirin and clopidogrel resistance: methodological challenges and opportunities. [20448796] Vasc Health Risk Manag 6(-): 109-12 (2010)
2011 39	Clinical evidence of interaction between clopidogrel and proton pump inhibitors. [21666816] World J Cardiol 3(5): 153-64 (2011)
2011 40	Genetic determinants of platelet response to clopidogrel. [21706290] J Thromb Thrombolysis 32(4): 459-66 (2011)
2011 41	CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel. [21332306] Pharmacogenomics 12(2): 141-4 (2011)
2010 42	The potential interaction between clopidogrel and proton pump inhibitors: a systematic review. [21134261] BMC Med 8(): 81 (2010)
PMC 43	Clopidogrel resistance - a clear problem with an unclear solution. [22929816] Indian Heart J 64(4):353-5 (2012)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Clopidogrel.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Clopidogrel.php on line 92